 Dr Jeanette Pritchard – General Manager
Appointed in 2006 by NanoVic, Jeanette is managing the Quintain NS portfolio. Jeanette gained over three years experience in managing and co-ordinating commercial projects at Sphere Medical Ltd. and Applied Enzyme Technology Ltd. in the UK, primarily for biosensor device development, protein stabilisation technologies and diagnostic Point-of-Care testing for medical and environmental applications. Jeanette’s PhD was awarded for her work at the University of Newcastle upon Tyne, which involved the development of lateral flow immunosensors for the electrochemical measurement of cardiac marker proteins.
 Dr Bob Irving – Business and Strategic Development
Scientific and Commercial Director for NanoVic for over four years, Bob is managing business and strategic developments for Quintain NS. Bob managed the Protein Diagnostics Program within the CRC for Diagnostics for four years and developed and commercialised the molecular evolution technologies to EvoGenix Pty Ltd. Bob also developed technologies for the start-up company Avipep and managed projects in biotech companies in Canada for 6 years. Bob’s PhD was awarded for his work at the Imperial Cancer Research Fund, London, on prostate cancer.
|
